Supply Chain

The reality of automation in CGT—Why closed systems matter: INFOGRAPHIC

The reality of automation in CGT—Why closed systems matter: INFOGRAPHIC

Streamlining the supply chain: insights on raw material sourcing and quality by design

Streamlining the supply chain: insights on raw material sourcing and quality by design

Raw and starting materials for cellular and gene therapy products

Raw and starting materials for cellular and gene therapy products

Understanding and mitigating risks associated with cryopreservation practices in cell therapy

Understanding and mitigating risks associated with cryopreservation practices in cell therapy

Advitiya Mahajan, Rachel Leon, Allison Hubel

Cryopreservation of autologous patient material for onwards manufacture

Cryopreservation of autologous patient material for onwards manufacture

Chris Leonforte

Essential equipment for advancing cell and gene therapy: innovations in incubation, monitoring, and cold storage

Essential equipment for advancing cell and gene therapy: innovations in incubation, monitoring, and cold storage

Digitalization and data analytics: shaping the future of cell bioprocessing

Digitalization and data analytics: shaping the future of cell bioprocessing

Ensuring compliance through collaboration: managing raw material changes in cell and gene therapy regulatory filings

Ensuring compliance through collaboration: managing raw material changes in cell and gene therapy regulatory filings

Kasey Kime, Xiao Peng

Innovator Insight

Streamlining the supply chain: insights on raw material sourcing and quality by design

Streamlining the supply chain: insights on raw material sourcing and quality by design

Choosing the best path to patients: how to decide between in-house and outsourced iPSC therapy development and manufacturing

Choosing the best path to patients: how to decide between in-house and outsourced iPSC therapy development and manufacturing

Laura Koivusalo, Anni Mörö, Ross Macdonald

Enabling allogeneic cell therapy development: scaling up generation of PSC-derived NK cells

Enabling allogeneic cell therapy development: scaling up generation of PSC-derived NK cells

Mark Kennedy, Marcus Bunn

Innovator Insight

Raw and starting materials for cellular and gene therapy products

Raw and starting materials for cellular and gene therapy products

1
2
3
4
5
6
7
8
9
10
...
>
>>

Lessons learned from an end-to-end digitization journey for advanced therapy workflows

Lessons learned from an end-to-end digitization journey for advanced therapy workflows

Emmanuel Casasola, Annie Prescott, Joseph Higdon

Strategic human raw material selection for cell therapy manufacturing

Strategic human raw material selection for cell therapy manufacturing

Daniel Benitez-Ribas

Optimizing iPSC-derived cell therapy development

Optimizing iPSC-derived cell therapy development

O Farah, M Kennedy, A Becker et al

To 1000L and beyond: streamlining AAV manufacturing with transfection complex stabilization

To 1000L and beyond: streamlining AAV manufacturing with transfection complex stabilization

Leisha Kopp, Mason Bonitz

Transforming viral vector manufacturing with next-generation CGMP plasmids platform

Transforming viral vector manufacturing with next-generation CGMP plasmids platform

John Bowen, Brian Tomkowicz

GMP or not? Understanding raw material quality grades and requirements for ATMP manufacturing

GMP or not? Understanding raw material quality grades and requirements for ATMP manufacturing

Lili Belcastro, Basak Clements, Claire Wartel

Advancing AAV manufacturing: strategic insights and cost-effective solutions for the future of gene therapies

Advancing AAV manufacturing: strategic insights and cost-effective solutions for the future of gene therapies

Michael DiBiasio-White, Ying Cai, Roland Pach

06 February 2025

Preserving the future of medicine: standardizing leukapheresis materials with cryopreservation for scalable cell therapies

Preserving the future of medicine: standardizing leukapheresis materials with cryopreservation for scalable cell therapies

R Luke, M Giedlin, D Clarke et al

12 December 2024

When does outsourcing autologous collection center qualification and the cell therapy supply chain make sense?

When does outsourcing autologous collection center qualification and the cell therapy supply chain make sense?

Amy Hines, Jeni Newman, Marcel van Houten

14 November 2024

1
2
3
4
5
6
7
8
>
>>